0
Get Alert
Please Wait... Processing your request... Please Wait.
You must sign in to sign-up for alerts.

Please confirm that your email address is correct, so you can successfully receive this alert.

1
INFLUENTIAL PUBLICATIONS   |    
Bibliography for Child and Adolescent Psychiatry
FOCUS 2008;6:314-316.
Abstract

This section contains a compilation of recent publications that have shaped the thinking in the field as well as classic works that remain important to the subject reviewed in this issue. This bibliography has been compiled by experts in the field and members of the editorial and advisory boards. Entries are listed chronologically and within years by first author. Articles from the bibliography that are reprinted in this issue are in bold type.

Abstract Teaser
Figures in this Article

Antshel KM, Barkley R: Psychosocial interventions in attention deficit hyperactivity disorder.  Child Adolesc Psychiatr Clin N Am 2008; 17: 421— 437
[PubMed]
[CrossRef]
 
Biederman J, Monuteaux MC, Spencer T, Wilens TE, Macpherson HA, Faraone SV: Stimulant therapy and risk for subsequent substance use disorders in male adults with ADHD: a naturalistic controlled 10-year follow-up study.  Am J Psychiatry 2008; 165: 597— 603
[PubMed]
[CrossRef]
 
Correll CU: Antipsychotic use in children and adolescents: minimizing adverse effects to maximize outcomes.  J Am Acad Child Adolesc Psychiatry 2008; 47: 9— 20
[PubMed]
[CrossRef]
 
Correll CU: Assessing and maximizing the safety and tolerability of antipsychotics used in the treatment of children and adolescents.  J Clin Psychiatry 2008; 69 ( suppl 4): 26— 36
[PubMed]
[CrossRef]
 
Emslie GJ, Kennard BD, Mayes TL, Nightingale-Teresi J, Carmody T, Hughes CW, Rush AJ, Tao R, Rintelmann JW: Fluoxetine versus placebo in preventing relapse of major depression in children and adolescents.  Am J Psychiatry 2008; 165: 459— 467
[PubMed]
[CrossRef]
 
Faraone SV, Biederman J, Morley CP, Spencer TJ. Effect of stimulants on height and weight: A review of the literature.  J Am Acad Child Adolesc Psychiatry . 2008, Jun 20
 
Galanter CA, Leibenluft E: Frontiers between attention deficit hyperactivity disorder and bipolar disorder.  Child Adolesc Psychiatr Clin N Am 2008; 17: 325— 346, viii— ix
[PubMed]
[CrossRef]
 
Leibenluft E, Rich BA: Pediatric bipolar disorder.  Annu Rev Clin Psychol 2008; 4: 163— 187
[PubMed]
[CrossRef]
 
Madaan V, Daughton J, Lubberstedt B, Mattai A, Vaughan BS, Kratochvil C: Assessing the efficacy of treatments for ADHD: overview of methodological issues.  CNS Drugs 2008; 22: 275— 290
[PubMed]
[CrossRef]
 
Mick E, Faraone SV: Genetics of attention deficit hyperactivity disorder.  Child Adolesc Psychiatr Clin N Am 2008; 17: 261— 284, vii— viii
[PubMed]
[CrossRef]
 
Parens E, Johnston J: Understanding the agreements and controversies surrounding childhood psychopharmacology.  Child Adolesc Psychiatry Ment Health 2008; 2: 5
[PubMed]
[CrossRef]
 
Swanson J, Arnold LE, Kraemer H, Hechtman L, Molina B, Hinshaw S, Vitiello B, Jensen P, Steinhoff K, Lerner M, Greenhill L, Abikoff H, Wells K, Epstein J, Elliott G, Newcorn J, Hoza B, Wigal T: Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the multimodal treatment study of children with ADHD (MTA): Part I: Executive summary.  J Atten Disord 2008; 12: 4— 14
[PubMed]
[CrossRef]
 
Swanson J, Arnold LE, Kraemer H, Hechtman L, Molina B, Hinshaw S, Vitiello B, Jensen P, Steinhoff K, Lerner M, Greenhill L, Abikoff H, Wells K, Epstein J, Elliott G, Newcorn J, Hoza B, Wigal T: Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the multimodal treatment study of children with ADHD (MTA): Part II: Supporting details.  J Atten Disord 2008; 12: 15— 43
[PubMed]
[CrossRef]
 
Vitiello B: Understanding the risk of using medications for attention deficit hyperactivity disorder with respect to physical growth and cardiovascular function.  Child Adolesc Psychiatr Clin N Am 2008; 17: 459— 474
[PubMed]
[CrossRef]
 
Watson HJ, Rees CS: Meta-analysis of randomized, controlled treatment trials for pediatric obsessive-compulsive disorder.  J Child Psychol Psychiatry 2008; 49: 489— 498
[PubMed]
[CrossRef]
 
Birmaher B, Brent D, AACAP Work Group on Quality Issues, Bernet W, Bukstein O, Walter H, Benson RS, Chrisman A, Farchione T, Greenhill L, Hamilton J, Keable H, Kinlan J, Schoettle U, Stock S, Ptakowski KK, Medicus J: Practice parameter for the assessment and treatment of children and adolescents with depressive disorders.  J Am Acad Child Adolesc Psychiatry 2007; 46: 1503— 1526
[PubMed]
[CrossRef]
 
Brent D: Antidepressants and suicidal behavior: cause or cure?  Am J Psychiatry 2007; 164: 989— 991
[PubMed]
[CrossRef]
 
Bukstein OG, Bernet W, Arnold V, Beitchman J, Shaw J, Benson RS, Kinlan J, McClellan J, Stock S, Ptakowski KK, Work Group on Quality Issues: Practice parameter for the assessment and treatment of children and adolescents with substance use disorders.  J Am Acad Child Adolesc Psychiatry 2005; 44: 609— 621. Reprinted in FOCUS 2007; 5:249—261
[PubMed]
[CrossRef]
 
Cohen LS: Treatment of bipolar disorder during pregnancy.  J Clin Psychiatry 2007; 68 ( Suppl 9): 4— 9
[CrossRef]
 
Connolly SD, Bernstein GA, Work Group on Quality Issues: Practice parameter for the assessment and treatment of children and adolescents with anxiety disorders.  J Am Acad Child Adolesc Psychiatry 2007; 46: 267— 283
[PubMed]
[CrossRef]
 
Couturier J, Lock J: A review of medication use for children and adolescents with eating disorders.  J Can Acad Child Adolesc Psychiatry 2007; 16: 173— 176
[PubMed]
 
Findling RL, Arnold LE, Greenhill LL, Kratochvil CJ, McGough JJ: Diagnosing and managing complicated ADHD.  J Clin Psychiatry 2007; 68: 1963— 1970
[PubMed]
[CrossRef]
 
Gleason MM, Egger HL, Emslie GJ, Greenhill LL, Kowatch RA, Lieberman AF, Luby JL, Owens J, Scahill LD, Scheeringa MS, Stafford B, Wise B, Zeanah CH: Psychopharmacological treatment for very young children: contexts and guidelines.  Am Acad Child Adolesc Psychiatry 2007; 46: 1532— 1572
[CrossRef]
 
Hughes CW, Emslie GJ, Crismon ML, Posner K, Birmaher B, Ryan N, Jensen P, Curry J, Vitiello B, Lopez M, Shon SP, Pliszka SR, Trivedi MH, Texas Consensus Conference Panel on Medication Treatment of Childhood Major Depressive Disorder: Texas Children's Medication Algorithm Project: update from Texas Consensus Conference Panel on Medication Treatment of Childhood Major Depressive Disorder.  J Am Acad Child Adolesc Psychiatry 2007; 46: 667— 686
[PubMed]
[CrossRef]
 
Jensen PS, Arnold LE, Swanson JM, Vitiello B, Abikoff HB, Greenhill LL, Hechtman L, Hinshaw SP, Pelham WE, Wells KC, Conners CK, Elliott GR, Epstein JN, Hoza B, March JS, Molina BS, Newcorn JH, Severe JB, Wigal T, Gibbons RD, Hur K: 3-year follow-up of the NIMH MTA study.  J Am Acad Child Adolesc Psychiatry 2007; 46: 989— 1002
[PubMed]
[CrossRef]
 
Leckman JF, King RA: A developmental perspective on the controversy surrounding the use of SSRIs to treat pediatric depression (editorial).  Am J Psychiatry 2007; 164: 1304— 1306
[PubMed]
[CrossRef]
 
March JS, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, Burns B, Domino M, McNulty S, Vitiello B, Severe J: The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes.  Arch Gen Psychiatry 2007; 64: 1132— 1143
[PubMed]
[CrossRef]
 
McClellan J, Kowatch R, Findling RL, Work Group on Quality Issues: Practice parameter for the assessment and treatment of children and adolescents with bipolar disorder.  J Am Acad Child Adolesc Psychiatry 2007; 46: 107— 125
[PubMed]
[CrossRef]
 
Moreno C, Laje G, Blanco C, Jiang H, Schmidt AB, Olfson M: National trends in the outpatient diagnosis and treatment of bipolar disorder in youth.  Arch Gen Psychiatry 2007; 64: 1032— 1039
[PubMed]
[CrossRef]
 
Myers SM, Johnson CP, American Academy of Pediatrics Council on Children with Disabilities: Management of children with autism spectrum disorders.  Pediatrics 2007; 120: 1162— 1182
[PubMed]
[CrossRef]
 
Myers SM. The status of pharmacotherapy for autism spectrum disorders.  Expert Opin Pharmacother 2007; 8: 1579— 603
[PubMed]
[CrossRef]
 
Pliszka S, AACAP Work Group on Quality Issues: Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder.  J Am Acad Child Adolesc Psychiatry 2007; 46: 894— 921
[PubMed]
[CrossRef]
 
Rutherford L, Couturier J: A review of psychotherapeutic interventions for children and adolescents with eating disorders.  J Can Acad Child Adolesc Psychiatry 2007; 16: 153— 157
[PubMed]
 
Simon GE, Savarino J: Suicide attempts among patients starting depression treatment with medications or psychotherapy.  Am J Psychiatry 2007; 164: 1029— 1034
[PubMed]
[CrossRef]
 
Smarty S, Findling RL: Psychopharmacology of pediatric bipolar disorder: a review.  Psychopharmacology (Berl) 2007; 191: 39— 54
[PubMed]
[CrossRef]
 
Steiner H, Remsing L, Work Group on Quality Issues: Practice parameter for the assessment and treatment of children and adolescents with oppositional defiant disorder.  J Am Acad Child Adolesc Psychiatry 2007; 46: 126— 141
[PubMed]
[CrossRef]
 
Stowe ZN: The use of mood stabilizers during breastfeeding.  J Clin Psychiatry 2007; 68 ( suppl 9): 22— 28
[CrossRef]
 
Birmaher B, Axelson D, Strober M, Gill MK, Valeri S, Chiappetta L, Ryan N, Leonard H, Hunt J, Iyengar S: Clinical course of children and adolescents with bipolar spectrum disorders.  Arch Gen Psychiatry 2006; 63: 175— 183
[PubMed]
[CrossRef]
 
Brotman MA, Schmajuk M, Rich BA, Dickstein DP, Guyer AE, Costello EJ, Egger HL, Angold A, Pine DS, Leibenluft E: Prevalence, clinical correlates, and longitudinal course of severe mood dysregulation in children.  Biol Psychiatry 2006; 60: 991— 997
[PubMed]
[CrossRef]
 
Carlson GA, Meyer SE: Diagnosis of bipolar disorder across the lifespan: complexities and developmental issues.  Dev Psychopathol 2006; 18: 939— 969
[PubMed]
 
Faraone SV, Biederman J, Mick E: The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies.  Psychol Med 2006; 36: 159— 165
[PubMed]
 
King BH, Bostic JQ: An update on pharmacologic treatments for autism spectrum disorders.  Child Adolesc Psychiatr Clin N Am 2006; 15: 161— 175
[PubMed]
[CrossRef]
 
Kowatch RA, DelBello MP: Pediatric bipolar disorder: emerging diagnostic and treatment approaches.  Child Adolesc Psychiatr Clin N Am 2006; 15: 73— 108
[PubMed]
[CrossRef]
 
Lecavalier l, Leone S, Wiltz J: The impact of behaviour problems on caregiver stress in young people with autism spectrum disorders.  J Intellect Disabil Res 2006; 50: 172— 183
[PubMed]
[CrossRef]
 
Pavone P, Parano E, Rizzo R, Trifiletti RR: Autoimmune neuropsychiatric disorders associated with streptococcal infection: Sydenham chorea, PANDAS, and PANDAS variants.  J Child Neurol 2006; 21: 727— 736
[PubMed]
[CrossRef]
 
Pidsosny IC, Virani A: Pediatric psychopharmacology update: psychostimulants and tics—past, present and future.  J Can Acad Child Adolesc Psychiatry 2006; 15: 84— 86
[PubMed]
 
Pliszka SR, Crismon ML, Hughes CW, Corners CK, Emslie GJ, Jensen PS, McCracken JT, Swanson JM, Lopez M, Texas Consensus Conference Panel on Pharmacotherapy of Childhood Attention Deficit Hyperactivity Disorder: The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder.  J Am Acad Child Adolesc Psychiatry 2006; 45: 642— 657
[PubMed]
[CrossRef]
 
Rutter M, Kim-Cohen J, Maughan B: Continuities and discontinuities in psychopathology between childhood and adult life.  J Am Acad Child Adolesc Psychiatry 2006; 47: 276— 295
 
Thomas LE, Woods SW: The schizophrenia prodrome: a developmentally informed review and update for psychopharmacologic treatment.  Child Adolesc Psychiatric Clin N Am 2006; 15: 109— 133
[CrossRef]
 
U.S. Food and Drug Administration (2006).  FDA Public Health Advisory: Treatment Challenges of Depression in Pregnancy and the Possibility of Persistent Pulmonary Hypertension in Newborns . http://www.fda.gov/cder/drug/advisory/SSRI_PPHN200607.htm
 
Wagner KD, Kowatch RA, Emslie GJ, Findling RL, Wilens TE, McCague K, D'Souza J, Wamil A, Lehman RB, Berv D, Linden D: A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents.  Am J Psychiatry 2006; 163: 1179— 1186
[PubMed]
[CrossRef]
 
Youngstrom E, Meyers O, Youngstrom JK, Calabrese JR, Findling RL: Diagnostic and measurement issues in the assessment of pediatric bipolar disorder: implications for understanding mood disorder across the life cycle.  Dev Psychopathol 2006; 18: 989— 1021
[PubMed]
 
Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA, Sklar P: Molecular genetics of attention-deficit/ hyperactivity disorder.  Biol Psychiatry 2005; 57: 1313— 1323
[PubMed]
[CrossRef]
 
McDougle CJ, Hollway J, Scahill L, Koenig K, Aman MQ, Mcgough JJ, McCracken JT, Ritz L, Tierney E, Vitiello B, Davies M, Arnold LE, Posey DJ, Martin A, Ghuman JK, Shah B, Chuang SZ, Swiezy NB, Gonzalez NM: Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology.  Am J Psychiatry 2005; 162: 1142— 1148
[PubMed]
[CrossRef]
 
Geller B, Tillman R, Craney JL, Bolhofner K: Four-year prospective outcome and natural history of mania in children with a prepubertal and early adolescent bipolar disorder phenotype.  Arch Gen Psychiatry 2004; 61: 459— 467
[PubMed]
[CrossRef]
 
Howlin P, Goode S, Hutton J, Rutter M: Adult outcome for children with autism.  J Child Psychol Psychiat 2004; 45: 212— 229
[PubMed]
[CrossRef]
 
Shaffer D: The suicidal adolescent.  Focus 2004; 2: 517— 523
 
Simonoff E, Elander J, Holmshaw J, Pickles A, Murray R, Rutter M: Predictors of antisocial personality: continuities from childhood to adult life.  Br J Psychiatry 2004; 184: 118— 127
[PubMed]
[CrossRef]
 
Zametkin AJ, Zoon CK, Klein HW, Munson S: Psychiatric aspects of child and adolescent obesity: a review of the past 10 years.  J Am Acad Child Adolesc Psychiatry 2004; 43: 134— 150. Reprinted in Focus 2004; 2:625—641
[PubMed]
[CrossRef]
 
Leibenluft E, Charney DS, Towbin KE, Bhangoo RK, Pine DS: Defining clinical phenotypes of juvenile mania.  Am J Psychiatry 2003; 160: 430— 437
[PubMed]
[CrossRef]
 
Laurence L Greenhill, Steven Pliszka, Mina K Dulcan, William Bernet, Valerie Arnold, Joseph Beitchman, R Scott Benson, Oscar Bukstein, Joan Kinlan, Jon McClellan, David Rue, Jon A Shaw, and Saundra Stock Practice Parameter for the Use of Stimulant Medications in the Treatment of Children, Adolescents, and Adults. J Am Acad Child Adolesc Psychiatry 2002; 41 ( 2suppl): 26S— 49S. Focus 2004 2: 642—668
[PubMed]
[CrossRef]
 
Lord C, Risi S, Lambrecht L, Cook EH, Leventhal BL, Dilavore PC, Pickles A, Rutter M: The Autism Diagnostic Observation Schedule—Generic: a standard measure of social and communication deficits associated with the spectrum of autism.  J Autism Dev Disord 2000; 30: 205— 223
[PubMed]
[CrossRef]
 
References Container
+

References

Antshel KM, Barkley R: Psychosocial interventions in attention deficit hyperactivity disorder.  Child Adolesc Psychiatr Clin N Am 2008; 17: 421— 437
[PubMed]
[CrossRef]
 
Biederman J, Monuteaux MC, Spencer T, Wilens TE, Macpherson HA, Faraone SV: Stimulant therapy and risk for subsequent substance use disorders in male adults with ADHD: a naturalistic controlled 10-year follow-up study.  Am J Psychiatry 2008; 165: 597— 603
[PubMed]
[CrossRef]
 
Correll CU: Antipsychotic use in children and adolescents: minimizing adverse effects to maximize outcomes.  J Am Acad Child Adolesc Psychiatry 2008; 47: 9— 20
[PubMed]
[CrossRef]
 
Correll CU: Assessing and maximizing the safety and tolerability of antipsychotics used in the treatment of children and adolescents.  J Clin Psychiatry 2008; 69 ( suppl 4): 26— 36
[PubMed]
[CrossRef]
 
Emslie GJ, Kennard BD, Mayes TL, Nightingale-Teresi J, Carmody T, Hughes CW, Rush AJ, Tao R, Rintelmann JW: Fluoxetine versus placebo in preventing relapse of major depression in children and adolescents.  Am J Psychiatry 2008; 165: 459— 467
[PubMed]
[CrossRef]
 
Faraone SV, Biederman J, Morley CP, Spencer TJ. Effect of stimulants on height and weight: A review of the literature.  J Am Acad Child Adolesc Psychiatry . 2008, Jun 20
 
Galanter CA, Leibenluft E: Frontiers between attention deficit hyperactivity disorder and bipolar disorder.  Child Adolesc Psychiatr Clin N Am 2008; 17: 325— 346, viii— ix
[PubMed]
[CrossRef]
 
Leibenluft E, Rich BA: Pediatric bipolar disorder.  Annu Rev Clin Psychol 2008; 4: 163— 187
[PubMed]
[CrossRef]
 
Madaan V, Daughton J, Lubberstedt B, Mattai A, Vaughan BS, Kratochvil C: Assessing the efficacy of treatments for ADHD: overview of methodological issues.  CNS Drugs 2008; 22: 275— 290
[PubMed]
[CrossRef]
 
Mick E, Faraone SV: Genetics of attention deficit hyperactivity disorder.  Child Adolesc Psychiatr Clin N Am 2008; 17: 261— 284, vii— viii
[PubMed]
[CrossRef]
 
Parens E, Johnston J: Understanding the agreements and controversies surrounding childhood psychopharmacology.  Child Adolesc Psychiatry Ment Health 2008; 2: 5
[PubMed]
[CrossRef]
 
Swanson J, Arnold LE, Kraemer H, Hechtman L, Molina B, Hinshaw S, Vitiello B, Jensen P, Steinhoff K, Lerner M, Greenhill L, Abikoff H, Wells K, Epstein J, Elliott G, Newcorn J, Hoza B, Wigal T: Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the multimodal treatment study of children with ADHD (MTA): Part I: Executive summary.  J Atten Disord 2008; 12: 4— 14
[PubMed]
[CrossRef]
 
Swanson J, Arnold LE, Kraemer H, Hechtman L, Molina B, Hinshaw S, Vitiello B, Jensen P, Steinhoff K, Lerner M, Greenhill L, Abikoff H, Wells K, Epstein J, Elliott G, Newcorn J, Hoza B, Wigal T: Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the multimodal treatment study of children with ADHD (MTA): Part II: Supporting details.  J Atten Disord 2008; 12: 15— 43
[PubMed]
[CrossRef]
 
Vitiello B: Understanding the risk of using medications for attention deficit hyperactivity disorder with respect to physical growth and cardiovascular function.  Child Adolesc Psychiatr Clin N Am 2008; 17: 459— 474
[PubMed]
[CrossRef]
 
Watson HJ, Rees CS: Meta-analysis of randomized, controlled treatment trials for pediatric obsessive-compulsive disorder.  J Child Psychol Psychiatry 2008; 49: 489— 498
[PubMed]
[CrossRef]
 
Birmaher B, Brent D, AACAP Work Group on Quality Issues, Bernet W, Bukstein O, Walter H, Benson RS, Chrisman A, Farchione T, Greenhill L, Hamilton J, Keable H, Kinlan J, Schoettle U, Stock S, Ptakowski KK, Medicus J: Practice parameter for the assessment and treatment of children and adolescents with depressive disorders.  J Am Acad Child Adolesc Psychiatry 2007; 46: 1503— 1526
[PubMed]
[CrossRef]
 
Brent D: Antidepressants and suicidal behavior: cause or cure?  Am J Psychiatry 2007; 164: 989— 991
[PubMed]
[CrossRef]
 
Bukstein OG, Bernet W, Arnold V, Beitchman J, Shaw J, Benson RS, Kinlan J, McClellan J, Stock S, Ptakowski KK, Work Group on Quality Issues: Practice parameter for the assessment and treatment of children and adolescents with substance use disorders.  J Am Acad Child Adolesc Psychiatry 2005; 44: 609— 621. Reprinted in FOCUS 2007; 5:249—261
[PubMed]
[CrossRef]
 
Cohen LS: Treatment of bipolar disorder during pregnancy.  J Clin Psychiatry 2007; 68 ( Suppl 9): 4— 9
[CrossRef]
 
Connolly SD, Bernstein GA, Work Group on Quality Issues: Practice parameter for the assessment and treatment of children and adolescents with anxiety disorders.  J Am Acad Child Adolesc Psychiatry 2007; 46: 267— 283
[PubMed]
[CrossRef]
 
Couturier J, Lock J: A review of medication use for children and adolescents with eating disorders.  J Can Acad Child Adolesc Psychiatry 2007; 16: 173— 176
[PubMed]
 
Findling RL, Arnold LE, Greenhill LL, Kratochvil CJ, McGough JJ: Diagnosing and managing complicated ADHD.  J Clin Psychiatry 2007; 68: 1963— 1970
[PubMed]
[CrossRef]
 
Gleason MM, Egger HL, Emslie GJ, Greenhill LL, Kowatch RA, Lieberman AF, Luby JL, Owens J, Scahill LD, Scheeringa MS, Stafford B, Wise B, Zeanah CH: Psychopharmacological treatment for very young children: contexts and guidelines.  Am Acad Child Adolesc Psychiatry 2007; 46: 1532— 1572
[CrossRef]
 
Hughes CW, Emslie GJ, Crismon ML, Posner K, Birmaher B, Ryan N, Jensen P, Curry J, Vitiello B, Lopez M, Shon SP, Pliszka SR, Trivedi MH, Texas Consensus Conference Panel on Medication Treatment of Childhood Major Depressive Disorder: Texas Children's Medication Algorithm Project: update from Texas Consensus Conference Panel on Medication Treatment of Childhood Major Depressive Disorder.  J Am Acad Child Adolesc Psychiatry 2007; 46: 667— 686
[PubMed]
[CrossRef]
 
Jensen PS, Arnold LE, Swanson JM, Vitiello B, Abikoff HB, Greenhill LL, Hechtman L, Hinshaw SP, Pelham WE, Wells KC, Conners CK, Elliott GR, Epstein JN, Hoza B, March JS, Molina BS, Newcorn JH, Severe JB, Wigal T, Gibbons RD, Hur K: 3-year follow-up of the NIMH MTA study.  J Am Acad Child Adolesc Psychiatry 2007; 46: 989— 1002
[PubMed]
[CrossRef]
 
Leckman JF, King RA: A developmental perspective on the controversy surrounding the use of SSRIs to treat pediatric depression (editorial).  Am J Psychiatry 2007; 164: 1304— 1306
[PubMed]
[CrossRef]
 
March JS, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, Burns B, Domino M, McNulty S, Vitiello B, Severe J: The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes.  Arch Gen Psychiatry 2007; 64: 1132— 1143
[PubMed]
[CrossRef]
 
McClellan J, Kowatch R, Findling RL, Work Group on Quality Issues: Practice parameter for the assessment and treatment of children and adolescents with bipolar disorder.  J Am Acad Child Adolesc Psychiatry 2007; 46: 107— 125
[PubMed]
[CrossRef]
 
Moreno C, Laje G, Blanco C, Jiang H, Schmidt AB, Olfson M: National trends in the outpatient diagnosis and treatment of bipolar disorder in youth.  Arch Gen Psychiatry 2007; 64: 1032— 1039
[PubMed]
[CrossRef]
 
Myers SM, Johnson CP, American Academy of Pediatrics Council on Children with Disabilities: Management of children with autism spectrum disorders.  Pediatrics 2007; 120: 1162— 1182
[PubMed]
[CrossRef]
 
Myers SM. The status of pharmacotherapy for autism spectrum disorders.  Expert Opin Pharmacother 2007; 8: 1579— 603
[PubMed]
[CrossRef]
 
Pliszka S, AACAP Work Group on Quality Issues: Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder.  J Am Acad Child Adolesc Psychiatry 2007; 46: 894— 921
[PubMed]
[CrossRef]
 
Rutherford L, Couturier J: A review of psychotherapeutic interventions for children and adolescents with eating disorders.  J Can Acad Child Adolesc Psychiatry 2007; 16: 153— 157
[PubMed]
 
Simon GE, Savarino J: Suicide attempts among patients starting depression treatment with medications or psychotherapy.  Am J Psychiatry 2007; 164: 1029— 1034
[PubMed]
[CrossRef]
 
Smarty S, Findling RL: Psychopharmacology of pediatric bipolar disorder: a review.  Psychopharmacology (Berl) 2007; 191: 39— 54
[PubMed]
[CrossRef]
 
Steiner H, Remsing L, Work Group on Quality Issues: Practice parameter for the assessment and treatment of children and adolescents with oppositional defiant disorder.  J Am Acad Child Adolesc Psychiatry 2007; 46: 126— 141
[PubMed]
[CrossRef]
 
Stowe ZN: The use of mood stabilizers during breastfeeding.  J Clin Psychiatry 2007; 68 ( suppl 9): 22— 28
[CrossRef]
 
Birmaher B, Axelson D, Strober M, Gill MK, Valeri S, Chiappetta L, Ryan N, Leonard H, Hunt J, Iyengar S: Clinical course of children and adolescents with bipolar spectrum disorders.  Arch Gen Psychiatry 2006; 63: 175— 183
[PubMed]
[CrossRef]
 
Brotman MA, Schmajuk M, Rich BA, Dickstein DP, Guyer AE, Costello EJ, Egger HL, Angold A, Pine DS, Leibenluft E: Prevalence, clinical correlates, and longitudinal course of severe mood dysregulation in children.  Biol Psychiatry 2006; 60: 991— 997
[PubMed]
[CrossRef]
 
Carlson GA, Meyer SE: Diagnosis of bipolar disorder across the lifespan: complexities and developmental issues.  Dev Psychopathol 2006; 18: 939— 969
[PubMed]
 
Faraone SV, Biederman J, Mick E: The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies.  Psychol Med 2006; 36: 159— 165
[PubMed]
 
King BH, Bostic JQ: An update on pharmacologic treatments for autism spectrum disorders.  Child Adolesc Psychiatr Clin N Am 2006; 15: 161— 175
[PubMed]
[CrossRef]
 
Kowatch RA, DelBello MP: Pediatric bipolar disorder: emerging diagnostic and treatment approaches.  Child Adolesc Psychiatr Clin N Am 2006; 15: 73— 108
[PubMed]
[CrossRef]
 
Lecavalier l, Leone S, Wiltz J: The impact of behaviour problems on caregiver stress in young people with autism spectrum disorders.  J Intellect Disabil Res 2006; 50: 172— 183
[PubMed]
[CrossRef]
 
Pavone P, Parano E, Rizzo R, Trifiletti RR: Autoimmune neuropsychiatric disorders associated with streptococcal infection: Sydenham chorea, PANDAS, and PANDAS variants.  J Child Neurol 2006; 21: 727— 736
[PubMed]
[CrossRef]
 
Pidsosny IC, Virani A: Pediatric psychopharmacology update: psychostimulants and tics—past, present and future.  J Can Acad Child Adolesc Psychiatry 2006; 15: 84— 86
[PubMed]
 
Pliszka SR, Crismon ML, Hughes CW, Corners CK, Emslie GJ, Jensen PS, McCracken JT, Swanson JM, Lopez M, Texas Consensus Conference Panel on Pharmacotherapy of Childhood Attention Deficit Hyperactivity Disorder: The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder.  J Am Acad Child Adolesc Psychiatry 2006; 45: 642— 657
[PubMed]
[CrossRef]
 
Rutter M, Kim-Cohen J, Maughan B: Continuities and discontinuities in psychopathology between childhood and adult life.  J Am Acad Child Adolesc Psychiatry 2006; 47: 276— 295
 
Thomas LE, Woods SW: The schizophrenia prodrome: a developmentally informed review and update for psychopharmacologic treatment.  Child Adolesc Psychiatric Clin N Am 2006; 15: 109— 133
[CrossRef]
 
U.S. Food and Drug Administration (2006).  FDA Public Health Advisory: Treatment Challenges of Depression in Pregnancy and the Possibility of Persistent Pulmonary Hypertension in Newborns . http://www.fda.gov/cder/drug/advisory/SSRI_PPHN200607.htm
 
Wagner KD, Kowatch RA, Emslie GJ, Findling RL, Wilens TE, McCague K, D'Souza J, Wamil A, Lehman RB, Berv D, Linden D: A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents.  Am J Psychiatry 2006; 163: 1179— 1186
[PubMed]
[CrossRef]
 
Youngstrom E, Meyers O, Youngstrom JK, Calabrese JR, Findling RL: Diagnostic and measurement issues in the assessment of pediatric bipolar disorder: implications for understanding mood disorder across the life cycle.  Dev Psychopathol 2006; 18: 989— 1021
[PubMed]
 
Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA, Sklar P: Molecular genetics of attention-deficit/ hyperactivity disorder.  Biol Psychiatry 2005; 57: 1313— 1323
[PubMed]
[CrossRef]
 
McDougle CJ, Hollway J, Scahill L, Koenig K, Aman MQ, Mcgough JJ, McCracken JT, Ritz L, Tierney E, Vitiello B, Davies M, Arnold LE, Posey DJ, Martin A, Ghuman JK, Shah B, Chuang SZ, Swiezy NB, Gonzalez NM: Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology.  Am J Psychiatry 2005; 162: 1142— 1148
[PubMed]
[CrossRef]
 
Geller B, Tillman R, Craney JL, Bolhofner K: Four-year prospective outcome and natural history of mania in children with a prepubertal and early adolescent bipolar disorder phenotype.  Arch Gen Psychiatry 2004; 61: 459— 467
[PubMed]
[CrossRef]
 
Howlin P, Goode S, Hutton J, Rutter M: Adult outcome for children with autism.  J Child Psychol Psychiat 2004; 45: 212— 229
[PubMed]
[CrossRef]
 
Shaffer D: The suicidal adolescent.  Focus 2004; 2: 517— 523
 
Simonoff E, Elander J, Holmshaw J, Pickles A, Murray R, Rutter M: Predictors of antisocial personality: continuities from childhood to adult life.  Br J Psychiatry 2004; 184: 118— 127
[PubMed]
[CrossRef]
 
Zametkin AJ, Zoon CK, Klein HW, Munson S: Psychiatric aspects of child and adolescent obesity: a review of the past 10 years.  J Am Acad Child Adolesc Psychiatry 2004; 43: 134— 150. Reprinted in Focus 2004; 2:625—641
[PubMed]
[CrossRef]
 
Leibenluft E, Charney DS, Towbin KE, Bhangoo RK, Pine DS: Defining clinical phenotypes of juvenile mania.  Am J Psychiatry 2003; 160: 430— 437
[PubMed]
[CrossRef]
 
Laurence L Greenhill, Steven Pliszka, Mina K Dulcan, William Bernet, Valerie Arnold, Joseph Beitchman, R Scott Benson, Oscar Bukstein, Joan Kinlan, Jon McClellan, David Rue, Jon A Shaw, and Saundra Stock Practice Parameter for the Use of Stimulant Medications in the Treatment of Children, Adolescents, and Adults. J Am Acad Child Adolesc Psychiatry 2002; 41 ( 2suppl): 26S— 49S. Focus 2004 2: 642—668
[PubMed]
[CrossRef]
 
Lord C, Risi S, Lambrecht L, Cook EH, Leventhal BL, Dilavore PC, Pickles A, Rutter M: The Autism Diagnostic Observation Schedule—Generic: a standard measure of social and communication deficits associated with the spectrum of autism.  J Autism Dev Disord 2000; 30: 205— 223
[PubMed]
[CrossRef]
 
References Container
+
+

CME Activity

There is currently no quiz available for this resource. Please click here to go to the CME page to find another.
Submit a Comments
Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
Comments are moderated and will appear on the site at the discertion of APA editorial staff.

* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe



Related Content
Articles
Books
The American Psychiatric Publishing Textbook of Psychiatry, 5th Edition > Chapter 36.  >
Dulcan's Textbook of Child and Adolescent Psychiatry > Chapter 30.  >
Dulcan's Textbook of Child and Adolescent Psychiatry > Chapter 30.  >
Dulcan's Textbook of Child and Adolescent Psychiatry > Chapter 30.  >
Dulcan's Textbook of Child and Adolescent Psychiatry > Chapter 52.  >
Topic Collections
Psychiatric News
PubMed Articles
Zonisamide for weight loss in adolescents. J Pediatr Pharmacol Ther 2013;18(4):311-4.